Cognition Therapeutics (CGTX) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cognition Therapeutics' VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit
GlobeNewswireFeb 25 07:30 ET
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer's Candidate, Zervimesine (CT1812)
GlobeNewswireFeb 20 07:30 ET
B.Riley Financial Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Raises Target Price to $2
Moomoo NewsFeb 6 09:33 ET · Ratings
Director Makes Bold Move With Major Stock Purchase in Cognition Therapeutics
TipRanksFeb 4 21:05 ET
Insider Purchase: CEO & President of $CGTX Buys 38,851 Shares
Quiver QuantitativeFeb 4 16:17 ET
Express News | Cognition’s Positive Phase 2 ‘Shimmer’ Study of Zervimesine (Ct1812) in Dementia With Lewy Bodies (Dlb) Will Be Presented in a Podium Presentation at Ilbdc
ReutersJan 30 07:30 ET

Comments

Teddy123

14 hours ago

Cognition Therapeutics’ VP of Research Co-hosting Precision Medicine Workshop at the Neuroimmunology Drug Development Summit

$Cognition Therapeutics (CGTX.US)$
Can This Biomarker Strategy Revolutionize Alzheimer's Treatment? Cognition's 95% Improvement Data

Teddy123

Feb 20 06:50

Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer’s Candidate, Zervimesine (CT1812)

$Cognition Therapeutics (CGTX.US)$
Inside Cognition's Game-Changing Manufacturing Process: Will This Transform Alzheimer's Drug Production?

Jaguar8

Feb 20 06:32

NEWS

$Cognition Therapeutics (CGTX.US)$
Cognition Therapeutics Announces Publication of Commercial Manufacturing Process for Lead Alzheimer's Candidate, Zervimesine (CT1812)
Thursday, 20th February at 7:30 am
- Chemical process enhances room temperature stability -
- Provisional patent applications filed -
PURCHASE, N.Y., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the "Company" or "Cognition") (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerat...

1

Jaguar8

Feb 17 16:44

🟡Watchlist, FEBRUARY 18,2025, Tuesday. NFA -DrJag8 - in progress. Will sleep first

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER...

131

5

6

Jaguar8

Feb 10 18:48

🟤Watchlist, FEBRUARY 11,2025, Tuesday. NFA - DrJag8

NOTE!
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, ...

77

10

5

CGTX Cognition Therapeutics

Trade Overview

Capital Trend

News

Comments